Tuberculosis assays: Past, present and future

Expert Review of Anti-Infective Therapy

Volumn 9, Issue 4, 2011, Pages 457-469

  Chegou, Novel N ^a   Hoek, Kim Gp ^b   Kriel, Magdalena ^a   Warren, Robin M ^a   Victor, Thomas C ^a   Walzl, Gerhard ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b UNIVERSITY OF STELLENBOSCH   (South Africa)

Author keywords

diagnostic test; latent tuberculosis infection; Mycobacterium tuberculosis; pulmonary tuberculosis; tuberculosis; tuberculosis diagnosis

Indexed keywords

DNA; GAMMA INTERFERON; TRANSRENAL DNA; UNCLASSIFIED DRUG;

ASSAY; CLINICAL EXAMINATION; COMPUTER ASSISTED TOMOGRAPHY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DISEASE MARKER; DNA SEQUENCE; GENOTYPE; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INTERFERON GAMMA RELEASE ASSAY; LATENT TUBERCULOSIS; LOOP MEDIATED ISOTHERMAL AMPLIFICATION; MIXED INFECTION; MOLECULAR BEACON; MYCOBACTERIUM TUBERCULOSIS; NUCLEIC ACID AMPLIFICATION; PHENOTYPE; POSITRON EMISSION TOMOGRAPHY; RADIODIAGNOSIS; REVIEW; SENSITIVITY AND SPECIFICITY; SEROLOGY; SPUTUM SMEAR; THORAX RADIOGRAPHY; TUBERCULOSIS;

ANTIBODIES, BACTERIAL; CHILD; FEMALE; HIV INFECTIONS; HUMANS; INTERFERON-GAMMA; LATENT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; PATHOLOGY, CLINICAL; PATHOLOGY, MOLECULAR; SPUTUM; TUBERCULOSIS; TUBERCULOSIS, PULMONARY;

EID: 79955103540     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/eri.11.23     Document Type: Review

References (144)

1. Iseman MD. A Clinician's Guide to Tuberculosis. Lippincott Williams & Wilkins, Philadelphia, PA, USA (2000).
2. WHO. Global Tuberculosis Control: a Short Update to the 2009 Report. WHO, Geneva, Switzerland (2010).
3. Wood R, Middelkoop K, Myer L et al. Undiagnosed tuberculosis in a community with high HIV prevalence: implications for tuberculosis control. Am. J. Respir. Crit. Care Med. 175(1), 87-93 (2007). (Pubitemid 46105314)
4. Stop TB Partnership, WHO. The Global Plan to Stop TB 2011-2015: Transforming the Fight Towards Elimination of Tuberculosis. WHO, Geneva, Switzerland (2010).
5. Botha E, den Boon S, Lawrence KA et al. From suspect to patient: tuberculosis diagnosis and treatment initiation in health facilities in South Africa. Int. J. Tuberc. Lung Dis. 12(8), 936-941 (2008).
6. Habib AG. A clinical and epidemiologic update on the interaction between tuberculosis and human immunodeficiency virus infection in adults. Ann. Afr. Med. 8(3), 147-155 (2009).
7. Marais BJ, Gupta A, Starke JR, El Sony A. Tuberculosis in women and children. Lancet 375(9731), 2057-2059 (2010).
8. Marais BJ, Gie RP, Schaaf HS, Beyers N, Donald PR, Starke JR. Childhood pulmonary tuberculosis: old wisdom and new challenges. Am. J. Respir. Crit. Care Med. 173(10), 1078-1090 (2006). (Pubitemid 43726888)
9. Tattevin P, Casalino E, Fleury L, Egmann G, Ruel M, Bouvet E. The validity of medical history, classic symptoms, and chest radiographs in predicting pulmonary tuberculosis: derivation of a pulmonary tuberculosis prediction model. Chest 115(5), 1248-1253 (1999). (Pubitemid 29230629)
10. Wejse C, Gustafson P, Nielsen J et al. TBscore: signs and symptoms from tuberculosis patients in a low-resource setting have predictive value and may be used to assess clinical course. Scand. J. Infect. Dis. 40(2), 111-120 (2008).
11. Miller LG, Asch SM, Yu EI, Knowles L, Gelberg L, Davidson P. A population-based survey of tuberculosis symptoms: how atypical are atypical presentations? Clin. Infect. Dis. 30(2), 293-299 (2000). (Pubitemid 30131536)
12. Siddiqi K, Lambert ML, Walley J. Clinical diagnosis of smear-negative pulmonary tuberculosis in low-income countries: the current evidence. Lancet Infect. Dis. 3(5), 288-296 (2003). (Pubitemid 36565881)
13. Frieden TR, Sterling TR, Munsiff SS, Watt CJ, Dye C. Tuberculosis. Lancet 362(9387), 887-899 (2003). (Pubitemid 37130100)
14. Graham S, Das GK, Hidvegi RJ et al. Chest radiograph abnormalities associated with tuberculosis: reproducibility and yield of active cases. Int. J. Tuberc. Lung Dis. 6(2), 137-142 (2002). (Pubitemid 34263704)
15. Lee KS, Song KS, Lim TH, Kim PN, Kim IY, Lee BH. Adult-onset pulmonary tuberculosis: findings on chest radiographs and CT scans. Am. J. Roentgenol. 160(4), 753-758 (1993).
16. Rathman G, Sillah J, Hill PC et al. Clinical and radiological presentation of 340 adults with smear-positive tuberculosis in The Gambia. Int. J. Tuberc. Lung Dis. 7(10), 942-947 (2003). (Pubitemid 37237056)
17. Goo JM, Im JG, Do KH et al. Pulmonary tuberculoma evaluated by means of FDG PET: findings in 10 cases. Radiology 216(1), 117-121 (2000). (Pubitemid 30434730)
18. Lee KS, Hwang JW, Chung MP, Kim H, Kwon OJ. Utility of CT in the evaluation of pulmonary tuberculosis in patients without AIDS. Chest 110(4), 977-984 (1996). (Pubitemid 26347613)
19. Hara T, Kosaka N, Suzuki T, Kudo K, Niino H. Uptake rates of 18F-fluorodeoxyglucose and 11C-choline in lung cancer and pulmonary tuberculosis: a positron emission tomography study. Chest 124(3), 893-901 (2003). (Pubitemid 37123306)
20. Pai M, Kalantri S, Dheda K. New tools and emerging technologies for the diagnosis of tuberculosis: part II. Active tuberculosis and drug resistance. Expert Rev. Mol. Diagn. 6(3), 423-432 (2006). (Pubitemid 44174346)
21. WHO. Global Tuberculosis Control 2008 - Surveillance, Planning, Financing. WHO, Geneva, Switzerland, 12, 1-304 (2008).
22. Hawken MP, Muhindi DW, Chakaya JM, Bhatt SM, Nǵanǵa LW, Porter JD. Under-diagnosis of smear-positive pulmonary tuberculosis in Nairobi, Kenya. Int. J. Tuberc. Lung Dis. 5(4), 360-363 (2001). (Pubitemid 32397587)
23. Apers L, Mutsvangwa J, Magwenzi J et al. A comparison of direct microscopy, the concentration method and the Mycobacteria Growth Indicator Tube for the examination of sputum for acid-fast bacilli. Int. J. Tuberc. Lung Dis. 7(4), 376-381 (2003). (Pubitemid 36433132)
24. Conde MB, Figueira CM, Moraes R, Fonseca LS, DeRiemer K, Kritski AL. Predictive value of the acid fast smear for detection of Mycobacterium tuberculosis in respiratory specimens in a reference center of HIV/AIDS in Rio de Janeiro, Brazil. Mem. Inst. Oswaldo Cruz 94(6), 787-790 (1999). (Pubitemid 129618926)
25. Davies PD, Pai M. The diagnosis and misdiagnosis of tuberculosis. Int. J. Tuberc. Lung Dis. 12(11), 1226-1234 (2008).
26. Steingart KR, Ng V, Henry M et al. Sputum processing methods to improve the sensitivity of smear microscopy for tuberculosis: a systematic review. Lancet Infect. Dis. 6(10), 664-674 (2006). (Pubitemid 44462695)
27. Steingart KR, Henry M, Ng V et al. Fluorescence versus conventional sputum smear microscopy for tuberculosis: a systematic review. Lancet Infect. Dis. 6(9), 570-581 (2006). (Pubitemid 44262344)
28. Marais BJ, Brittle W, Painczyk K et al. Use of light-emitting diode fluorescence microscopy to detect acid-fast bacilli in sputum. Clin. Infect. Dis. 47(2), 203-207 (2008). (Pubitemid 351920621)
29. Palomino JC. Newer diagnostics for tuberculosis and multi-drug resistant tuberculosis. Curr. Opin. Pulm. Med. 12(3), 172-178 (2006). (Pubitemid 44350471)
30. Drobniewski FA, Caws M, Gibson A, Young D. Modern laboratory diagnosis of tuberculosis. Lancet Infect. Dis. 3(3), 141-147 (2003). (Pubitemid 36278123)
31. Lee JJ, Suo J, Lin CB, Wang JD, Lin TY, Tsai YC. Comparative evaluation of the BACTEC MGIT 960 system with solid medium for isolation of mycobacteria. Int. J. Tuberc. Lung Dis. 7(6), 569-574 (2003). (Pubitemid 36713255)
32. Somoskovi A, Kodmon C, Lantos A et al. Comparison of recoveries of Mycobacterium tuberculosis using the automated BACTEC MGIT 960 system, the BACTEC 460 TB system, and Lowenstein-Jensen medium. J. Clin. Microbiol. 38(6), 2395-2397 (2000). (Pubitemid 30414375)
33. Tortoli E, Cichero P, Chirillo MG et al. Multicenter comparison of ESP Culture System II with BACTEC 460TB and with Lowenstein-Jensen medium for recovery of mycobacteria from different clinical specimens, including blood. J. Clin. Microbiol. 36(5), 1378-1381 (1998). (Pubitemid 28208031)
34. Perkins MD, Cunningham J. Facing the crisis: improving the diagnosis of tuberculosis in the HIV era. J. Infect. Dis. 196(Suppl. 1), S15-S27 (2007). (Pubitemid 47206081)
35. Kim SJ. Drug-susceptibility testing in tuberculosis: methods and reliability of results. Eur. Respir. J. 25(3), 564-569 (2005). (Pubitemid 40331189)
36. Drobniewski F, Rusch-Gerdes S, Hoffner S. Antimicrobial susceptibility testing of Mycobacterium tuberculosis (EUCAST document E.DEF 8.1)-report of the Subcommittee on Antimicrobial Susceptibility Testing of Mycobacterium tuberculosis of the European Committee for Antimicrobial Susceptibility Testing (EUCAST) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID).Clin. Microbiol. Infect. 13(12), 1144-1156 (2007). (Pubitemid 350056119)
37. Johnson R, Jordaan AM, Pretorius L et al. Ethambutol resistance testing by mutation detection. Int. J. Tuberc. Lung Dis. 10(1), 68-73 (2006). (Pubitemid 43266280)
38. Robledo JA, Mejia GI, Morcillo N et al. Evaluation of a rapid culture method for tuberculosis diagnosis: a Latin American multi-center study. Int. J. Tuberc. Lung Dis. 10(6), 613-619 (2006). (Pubitemid 43845021)
39. Martin A, Paasch F, Von GA et al. Thin-layer agar for detection of resistance to rifampicin, ofloxacin and kanamycin in Mycobacterium tuberculosis isolates. Int. J. Tuberc. Lung Dis. 13(10), 1301-1304 (2009).
40. Bwanga F, Hoffner S, Haile M, Joloba ML. Direct susceptibility testing for multi drug resistant tuberculosis: a meta-analysis. BMC Infect. Dis. 9, 67 (2009).
41. Yajko DM, Madej JJ, Lancaster MV, et al. Colorimetric method for determining MICs of antimicrobial agents for Mycobacterium tuberculosis. J. Clin. Microbiol. 33, 2324-2327 (1995).
42. Martin A, Morcillo N, Lemus D et al. Multicenter study of MTT and resazurin assays for testing susceptibility to first-line anti-tuberculosis drugs. Int. J. Tuberc. Lung Dis. 9(8), 901-906 (2005). (Pubitemid 41139650)
43. Angeby KA, Klintz L, Hoffner SE. Rapid and inexpensive drug susceptibility testing of Mycobacterium tuberculosis with a nitrate reductase assay. J. Clin. Microbiol. 40(2), 553-555 (2002). (Pubitemid 34130881)
44. Pai M, Kalantri S, Pascopella L, Riley LW, Reingold AL. Bacteriophage-based assays for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis: a meta-analysis. J. Infect. 51(3), 175-187 (2005). (Pubitemid 41554824)
45. Tortoli E. Impact of genotypic studies on mycobacterial taxonomy: the new mycobacteria of the 1990s. Clin. Microbiol. Rev. 16(2), 319-354 (2003). (Pubitemid 36519815)
46. Richter E, Rüsch-Gerdes S, Hillemann D. Drug-susceptibility testing in TB: current status and future prospects. Expert Rev. Respir. Med. 3(5), 497-510 (2009).
47. Ling DI, Zwerling AA, Pai M. GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analysis. Eur. Respir. J. 32(5), 1165-1174 (2008).
48. Morgan M, Kalantri S, Flores L, Pai M. A commercial line probe assay for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis. BMC Infect. Dis. 5, 62 (2005).
49. Barnard M, Albert H, Coetzee G, O'Brien R, Bosman ME. Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa. Am. J. Respir. Crit. Care Med. 177(7), 787-792 (2008). (Pubitemid 351490566)
50. Hillemann D, Rusch-Gerdes S, Richter E. Feasibility of the GenoType MTBDRsl assay for fluoroquinolone, amikacin- capreomycin, and ethambutol resistance testing of Mycobacterium tuberculosis strains and clinical specimens. J. Clin. Microbiol. 47(6), 1767-1772 (2009).
51. Kiet VS, Lan NT, An DD et al. Evaluation of the MTBDRsl test for detection of second-line-drug resistance in Mycobacterium tuberculosis. J. Clin Microbiol. 48(8), 2934-2939 (2010).
52. Helb D, Jones M, Story E et al. Rapid detection of Mycobacterium tuberculosis and rifampin-resistance using on-demand, near patient technology. J. Clin. Microbiol. 48(1), 229-237 (2009).
53. Raja S, Ching J, Xi L et al. Technology for automated, rapid, and quantitative PCR or reverse transcription-PCR clinical testing. Clin. Chem. 51(5), 882-890 (2005). (Pubitemid 40577926)
54. Boehme CC, Nabeta P, Hillemann D et al. Rapid molecular detection of tuberculosis and rifampicin resistance. N. Engl. J. Med. 363(11), 1070-1081 (2010).
55. Piatek AS, Telenti A, Murray MR et al. Genotypic analysis of Mycobacterium tuberculosis in two distinct populations using molecular beacons: implications for rapid susceptibility testing. Antimicrob. Agents Chemother. 44(1), 103-110 (2000). (Pubitemid 30010679)
56. Zhu RY, Zhang KX, Zhao MQ et al. Use of visual loop-mediated isotheral amplification of rimM sequence for rapid detection of Mycobacterium tuberculosis and Mycobacterium bovis. J. Microbiol. Methods 78(3), 339-343 (2009).
57. Tomita N, Mori Y, Kanda H, Notomi T. Loop-mediated isothermal amplification (LAMP) of gene sequences and simple visual detection of products. Nat. Protoc. 3(5), 877-882 (2008). (Pubitemid 351639031)
58. Iwamoto T, Sonobe T, Hayashi K. Loop-mediated isothermal amplification for direct detection of Mycobacterium tuberculosis complex, M. avium, and M. intracellulare in sputum samples. J. Clin. Microbiol. 41(6), 2616-2622 (2003). (Pubitemid 36712475)
59. Pandey BD, Poudel A, Yoda T et al. Development of an in-house loop-mediated isothermal amplification (LAMP) assay for detection of Mycobacterium tuberculosis and evaluation in sputum samples of Nepalese patients. J. Med. Microbiol. 57(Pt 4), 439-443 (2008). (Pubitemid 351537017)
60. Boehme CC, Nabeta P, Henostroza G et al. Operational feasibility of using loop-mediated isothermal amplification for diagnosis of pulmonary tuberculosis in microscopy centers of developing countries. J. Clin. Microbiol. 45(6), 1936-1940 (2007). (Pubitemid 46933929)
61. Cannas A, Goletti D, Girardi E et al. Mycobacterium tuberculosis DNA detection in soluble fraction of urine from pulmonary tuberculosis patients. Int. J. Tuberc. Lung Dis. 12(2), 146-151 (2008). (Pubitemid 351212405)
62. Aceti A, Zanetti S, Mura MS et al. Identification of HIV patients with active pulmonary tuberculosis using urine based polymerase chain reaction assay. Thorax 54(2), 145-146 (1999). (Pubitemid 29101359)
63. Sarmiento OL, Weigle KA, Alexander J, Weber DJ, Miller WC. Assessment by meta-analysis of PCR for diagnosis of smear-negative pulmonary tuberculosis. J. Clin. Microbiol. 41(7), 3233-3240 (2003). (Pubitemid 36842327)
64. Ling DI, Flores LL, Riley LW, Pai M. Commercial nucleic-acid amplification tests for diagnosis of pulmonary tuberculosis in respiratory specimens: meta-analysis and meta-regression. PLoS ONE 3(2), e1536 (2008).
65. Dinnes J, Deeks J, Kunst H et al. A systematic review of rapid diagnostic tests for the detection of tuberculosis infection. Health Technol. Assess. 11(3), 1-196 (2007).
66. Reid MJ, Shah NS. Approaches to tuberculosis screening and diagnosis in people with HIV in resource-limited settings. Lancet Infect. Dis. 9(3), 173-184 (2009).
67. Sakula A. Robert Koch: centenary of the discovery of the tubercle bacillus, 1882. Thorax 37(4), 246-251 (1982). (Pubitemid 12108474)
68. Shingadia D, Novelli V. The tuberculin skin test: a hundred, not out? Arch. Dis. Child. 93(3), 189-190 (2008). (Pubitemid 352025482)
69. Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann. Intern. Med. 146(5), 340-354 (2007). (Pubitemid 351650594)
70. Diagnostic Standards and Classification of Tuberculosis in Adults and Children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. This statement was endorsed by the Council of the Infectious Disease Society of America, September 1999. Am. J. Respir. Crit. Care Med. 161(4 Pt 1), 1376-1395 (2000).
71. Watkins RE, Brennan R, Plant AJ. Tuberculin reactivity and the risk of tuberculosis: a review. Int. J. Tuberc. Lung Dis. 4(10), 895-903 (2000).
72. Stout JE, Menzies D. Predicting tuberculosis: does the IGRA tell the tale? Am. J. Respir. Crit. Care Med. 177(10), 1055-1057 (2008). (Pubitemid 351717561)
73. van Pinxteren LA, Ravn P, Agger EM, Pollock J, Andersen P. Diagnosis of tuberculosis based on the two specific antigens ESAT-6 and CFP10. Clin. Diagn. Lab. Immunol. 7(2), 155-160 (2000). (Pubitemid 30132105)
74. Lalvani A. Diagnosing tuberculosis infection in the 21st Century: new tools to tackle an old enemy. Chest 131(6), 1898-1906 (2007). (Pubitemid 46981652)
75. Lalvani A, Millington KA. T cell-based diagnosis of childhood tuberculosis infection. Curr. Opin. Infect. Dis. 20(3), 264-271 (2007). (Pubitemid 46686008)
76. Pai M, Riley LW, Colford JM Jr. Interferon-γ assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect. Dis. 4(12), 761-776 (2004).
77. Pai M, Kalantri S, Dheda K. New tools and emerging technologies for the diagnosis of tuberculosis: part I. Latent tuberculosis. Expert Rev. Mol. Diagn. 6(3), 413-422 (2006). (Pubitemid 44174345)
78. Pai M, O'Brien R. New diagnostics for latent and active tuberculosis: state of the art and future prospects. Semin. Respir. Crit. Care Med. 29(5), 560-568 (2008).
79. Sester M, Sotgiu G, Lange C et al. Interferon-γ release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis. Eur. Respir. J. DOI: 10.1183/ 09031936.00114810 (2010) (Epub ahead of print).
80. Richeldi L. An update on the diagnosis of tuberculosis infection. Am. J. Respir. Crit. Care Med. 174(7), 736-742 (2006). (Pubitemid 44511654)
81. Hill PC, Jackson-Sillah D, Donkor SA, Otu J, Adegbola RA, Lienhardt C. Risk factors for pulmonary tuberculosis: a clinic-based case control study in The Gambia. BMC Public Health 6, 156 (2006).
82. Lienhardt C, Sillah J, Fielding K et al. Risk factors for tuberculosis infection in children in contact with infectious tuberculosis cases in the Gambia, West Africa. Pediatrics 111(5 Pt 1), e608-e614 (2003).
83. Hesseling AC, Mandalakas AM, Kirchner HL et al. Highly discordant T cell responses in individuals with recent exposure to household tuberculosis. Thorax 64(10), 840-846 (2009).
84. Mandalakas AM, Hesseling AC, Chegou NN et al. High level of discordant IGRA results in HIV-infected adults and children. Int. J. Tuberc. Lung Dis. 12(4), 417-423 (2008). (Pubitemid 351507255)
85. Shams H, Weis SE, Klucar P et al. Enzyme-linked immunospot and tuberculin skin testing to detect latent tuberculosis infection. Am. J. Respir. Crit. Care Med. 172(9), 1161-1168 (2005). (Pubitemid 43066653)
86. Aichelburg MC, Rieger A, Breitenecker F et al. Detection and prediction of active tuberculosis disease by a whole-blood interferon-γ release assay in HIV-1-infected individuals. Clin. Infect. Dis. 48(7), 954-962 (2009).
87. Diel R, Loddenkemper R, Meywald-Walter K, Niemann S, Nienhaus A. Predictive value of a whole blood IFN-γ assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis. Am. J. Respir. Crit. Care Med. 177(10), 1164-1170 (2008). (Pubitemid 351717577)
88. Diel R, Goletti D, Ferrara G et al. Interferon-γ release assays for the diagnosis of latent M. tuberculosis infection: a systematic review and meta-analysis. Eur. Respir. J. 37(1), 88-89 (2010).
89. Kik SV, Franken WPJ, Mensen M et al. Predictive value for progression to tuberculosis by IGRA and TST in immigrant contacts. Eur. Respir. J. 35(6), 1346-1353 (2010).
90. Clark SA, Martin SL, Pozniak A et al. Tuberculosis antigen-specific immune responses can be detected using enzyme-linked immunospot technology in human immunodeficiency virus (HIV)-1 patients with advanced disease. Clin. Exp. Immunol. 150(2), 238-244 (2007). (Pubitemid 47609557)
91. Todd B. The Quantiferon TB Gold Test. A new blood assay offers a promising alternative in tuberculosis testing. Am. J. Nurs. 106(6), 33-37 (2006).
92. Liebeschuetz S, Bamber S, Ewer K, Deeks J, Pathan AA, Lalvani A. Diagnosis of tuberculosis in South African children with a T-cell-based assay: a prospective cohort study. Lancet 364(9452), 2196-2203 (2004). (Pubitemid 40018449)
93. Dheda K, Smit RZ, Badri M, Pai M. T-cell interferon-γ release assays for the rapid immunodiagnosis of tuberculosis: clinical utility in high-burden vs. low-burden settings. Curr. Opin. Pulm. Med. 15(3), 188-200 (2009).
94. Hill PC, Brookes RH, Fox A et al. Surprisingly high specificity of the PPD skin test for M. tuberculosis infection from recent exposure in The Gambia. PLoS ONE 1, e68 (2006).
95. Kampmann B, Whittaker E, Williams A et al. Interferon-γ release assays do not identify more children with active tuberculosis than the tuberculin skin test. Eur. Respir. J. 33(6), 1374-1382 (2009).
96. Ravn P, Munk ME, Andersen AB et al. Prospective evaluation of a whole-blood test using Mycobacterium tuberculosis-specific antigens ESAT-6 and CFP-10 for diagnosis of active tuberculosis. Clin. Diagn. Lab. Immunol. 12(4), 491-496 (2005). (Pubitemid 41175315)
97. Kobashi Y, Mouri K, Yagi S et al. Clinical evaluation for diagnosing active TB disease and transitional change of two commercial blood tests. Scand. J. Infect. Dis. 40(8), 629-634 (2008).
98. Mori T, Sakatani M, Yamagishi F et al. Specific detection of tuberculosis infection: an interferon-γ-based assay using new antigens. Am. J. Respir. Crit. Care Med. 170(1), 59-64 (2004). (Pubitemid 38997752)
99. Wang JY, Chou CH, Lee LN et al. Diagnosis of tuberculosis by an enzyme-linked immunospot assay for interferon-γ. Emerg. Infect. Dis. 13(4), 553-558 (2007).
100. Goletti D, Carrara S, Mayanja-Kizza H et al. Response to M. tuberculosis selected RD1 peptides in Ugandan HIV-infected patients with smear positive pulmonary tuberculosis: a pilot study. BMC Infect. Dis. 8, 11 (2008).
101. Rangaka MX, Diwakar L, Seldon R et al. Clinical, immunological, and epidemiological importance of antituberculosis T cell responses in HIV-infected Africans. Clin. Infect. Dis. 44(12), 1639-1646 (2007). (Pubitemid 46871513)
102. Goletti D, Vincenti D, Carrara S et al. Selected RD1 peptides for active tuberculosis diagnosis: comparison of a g interferon whole-blood enzyme-linked immunosorbent assay and an enzyme-linked immunospot assay. Clin. Diagn. Lab. Immunol. 12(11), 1311-1316 (2005). (Pubitemid 41626601)
103. Chegou NN, Walzl G, Bolliger CT, Diacon AH, van den Heuvel MM. Evaluation of adapted whole-blood interferon-γ release assays for the diagnosis of pleural tuberculosis. Respiration 76(2), 131-138 (2008).
104. Baba K, Sornes S, Hoosen AA et al. Evaluation of immune responses in HIV infected patients with pleural tuberculosis by the QuantiFERON TB-Gold interferon-γ assay. BMC Infect. Dis. 8, 35 (2008).
105. Wilkinson KA, Wilkinson RJ, Pathan A et al. Ex vivo characterization of early secretory antigenic target 6-specific T cells at sites of active disease in pleural tuberculosis. Clin. Infect. Dis. 40(1), 184-187 (2005). (Pubitemid 40053478)
106. Losi M, Bossink A, Codecasa L et al. Use of a T-cell interferon γ release assay for the diagnosis of tuberculous pleurisy. Eur. Respir. J. 30(6), 1173-1179 (2007). (Pubitemid 351194766)
107. Dheda K, Van-Zyl Smit RN, Sechi LA et al. Utility of quantitative T cell responses versus unstimulated IFN-γ for the diagnosis of pleural tuberculosis. Eur. Respir. J. 34(5), 1118-1126 (2009).
108. Joshi R, Pai M. Can pleural tuberculosis be diagnosed using interferon-γ release assays? Respiration 76(2), 128-130 (2008).
109. Ariga H, Kawabe Y, Nagai H et al. Diagnosis of active tuberculous serositis by antigen-specific interferon-γ response of cavity fluid cells. Clin. Infect. Dis. 45(12), 1559-1567 (2007). (Pubitemid 351411839)
110. Jafari C, Ernst M, Kalsdorf B et al. Rapid diagnosis of smear-negative tuberculosis by bronchoalveolar lavage enzyme-linked immunospot. Am. J. Respir. Crit. Care Med. 174(9), 1048-1054 (2006). (Pubitemid 44684455)
111. Jafari C, Ernst M, Strassburg A et al. Local immunodiagnosis of pulmonary tuberculosis by enzyme-linked immunospot. Eur. Respir. J. 31(2), 261-265 (2008).
112. Murakami S, Takeno M, Oka H et al. Diagnosis of tuberculous meningitis due to detection of ESAT-6-specific g interferon production in cerebrospinal fluid enzyme-linked immunospot assay. Clin. Vaccine Immunol. 15(5), 897-899 (2008). (Pubitemid 351967036)
113. Masungi C, Temmerman S, Van Vooren JP et al. Differential T and B cell responses against Mycobacterium tuberculosis heparin-binding hemagglutinin adhesin in infected healthy individuals and patients with tuberculosis. J. Infect. Dis. 185(4), 513-520 (2002). (Pubitemid 34142814)
114. + T lymphocytes in latent human tuberculosis. J. Infect. Dis. 192(2), 226-232 (2005). (Pubitemid 40993392)
115. Hougardy JM, Schepers K, Place S et al. Heparin-binding-hemagglutinin- induced IFN-γ release as a diagnostic tool for latent tuberculosis. PLoS ONE 2(10), e926 (2007).
116. Fu R, Wang C, Shi C et al. An improved whole-blood g interferon assay based on the CFP21-MPT64 fusion protein. Clin. Vaccine Immunol. 16(5), 686-691 (2009).
117. Savolainen L, Pusa L, Kim HJ, Sillanpaa H, Seppala I, Tuuminen T. Pilot study of diagnostic potential of the Mycobacterium tuberculosis recombinant HBHA protein in a vaccinated population in Finland. PLoS ONE 3(9), e3272 (2008).
118. Ruhwald M, Petersen J, Kofoed K et al. Improving T-cell assays for the diagnosis of latent TB infection: potential of a diagnostic test based on IP-10. PLoS ONE 3(8), e2858 (2008).
119. Ruhwald M, Bodmer T, Maier C et al. Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis. Eur. Respir. J. 32(6), 1607-1615 (2008).
120. Whittaker E, Gordon A, Kampmann B. Is IP-10 a better biomarker for active and latent tuberculosis in children than IFNγ? PLoS ONE 3(12), e3901 (2008).
121. Chegou NN, Black GF, Kidd M, van Helden PD, Walzl G. Host markers in Quantiferon supernatants differentiate active TB from latent TB infection: preliminary report. BMC Pulm. Med. 9(1), 21 (2009).
122. Goletti D, Raja A, Ahamed Kabeer BS et al. IFN-γ, but not IP-10, MCP-2 or IL-2 response to RD1 selected peptides associates to active tuberculosis. J. Infect. 61(2), 133-143 (2010).
123. Goletti D, Raja A, Syed Ahamed KB et al. Is IP-10 an accurate marker for detecting M. tuberculosis-specific response in HIV-infected persons? PLoS ONE 5(9), e12577 (2010).
124. Diacon AH, Van de Wal BW, Wyser C et al. Diagnostic tools in tuberculous pleurisy: a direct comparative study. Eur. Respir. J. 22(4), 589-591 (2003). (Pubitemid 37258534)
125. Greco S, Girardi E, Masciangelo R, Capoccetta GB, Saltini C. Adenosine deaminase and interferon γ measurements for the diagnosis of tuberculous pleurisy: a meta-analysis. Int. J. Tuberc. Lung Dis. 7(8), 777-786 (2003). (Pubitemid 36987942)
126. Baba K, Hoosen AA, Langeland N, Dyrhol-Riise AM. Adenosine deaminase activity is a sensitive marker for the diagnosis of tuberculous pleuritis in patients with very low CD4 counts. PLoS ONE 3(7), e2788 (2008).
127. Jiang J, Shi HZ, Liang QL, Qin SM, Qin XJ. Diagnostic value of interferon-γ in tuberculous pleurisy: a metaanalysis. Chest 131(4), 1133-1141 (2007). (Pubitemid 46608717)
128. Aoe K, Hiraki A, Murakami T et al. Diagnostic significance of interferon-γ in tuberculous pleural effusions. Chest 123(3), 740-744 (2003). (Pubitemid 36315487)
129. Hiraki A, Aoe K, Eda R et al. Comparison of six biological markers for the diagnosis of tuberculous pleuritis. Chest 125(3), 987-989 (2004). (Pubitemid 38367290)
130. Krenke R, Korczynski P. Use of pleural fluid levels of adenosine deaminase and interferon γ in the diagnosis of tuberculous pleuritis. Curr. Opin. Pulm. Med. 16(4), 367-375 (2010).
131. Djoba Siawaya JF, Chegou NN, van den Heuvel MM et al. Differential cytokine/ chemokines and KL-6 profiles in patients with different forms of tuberculosis. Cytokine 47(2), 132-136 (2009).
132. Demir T, Yalcinoz C, Keskinel I, Demiroz F, Yildirim N. sICAM-1 as a serum marker in the diagnosis and follow-up of treatment of pulmonary tuberculosis. Int. J. Tuberc. Lung Dis. 6(2), 155-159 (2002). (Pubitemid 34263707)
133. Fuchs D, Hausen A, Kofler M, Kosanowski H, Reibnegger G, Wachter H. Neopterin as an index of immune response in patients with tuberculosis. Lung 162(1), 337-346 (1984). (Pubitemid 15223278)
134. Cannas A, Calvo L, Chiacchio T et al. IP-10 detection in urine is associated with lung diseases. BMC Infect. Dis. 10, 333 (2010).
135. Singh M, Espitia C. Immunological diagnosis. In:Tuberculosis 2007: From Basic Science to Patient Care. Palomino JC, Leao SC, Ritacco V (Eds).BourcillierKamps. com, 425-440 (2007)
136. Abebe F, Holm-Hansen C, Wiker HG, Bjune G. Progress in serodiagnosis of Mycobacterium tuberculosis infection. Scand. J. Immunol. 66(2-3), 176-191 (2007). (Pubitemid 47063204)
137. Steingart KR, Dendukuri N, Henry M et al. Performance of purified antigens for serodiagnosis of pulmonary tuberculosis: a meta-analysis. Clin. Vaccine Immunol. 16(2), 260-276 (2009).
138. Verma RK, Jain A. Antibodies to mycobacterial antigens for diagnosis of tuberculosis. FEMS Immunol. Med. Microbiol. 51(3), 453-461 (2007). (Pubitemid 350076155)
139. Steingart KR, Henry M, Laal S et al. Commercial serological antibody detection tests for the diagnosis of pulmonary tuberculosis: a systematic review. PLoS Med. 4(6), e202 (2007).
140. Steingart KR, Ramsay A, Pai M. Commercial serological tests for the diagnosis of tuberculosis: do they work? Future Microbiol. 2, 355-359 (2007). (Pubitemid 47365019)
141. Ireton GC, Greenwald R, Liang H, Esfandiari J, Lyashchenko KP, Reed SG. Identification of Mycobacterium tuberculosis antigens of high serodiagnostic value. Clin. Vaccine Immunol. 17(10), 1539-1547 (2010).
142. Mudaliar AV, Kashyap RS, Purohit HJ, Taori GM, Daginawala HF. Detection of 65 kD heat shock protein in cerebrospinal fluid of tuberculous meningitis patients. BMC Neurol. 6, 34 (2006).
143. Rajan AN, Kashyap RS, Purohit HJ, Taori GM, Daginawala HF. Serodiagnosis of tuberculosis based on the analysis of the 65 kD heat shock protein of Mycobacterium tuberculosis. Int. J. Tuberc. Lung Dis. 11(7), 792-797 (2007). (Pubitemid 47056990)
144. Weldingh K, Rosenkrands I, Okkels LM, Doherty TM, Andersen P. Assessing the serodiagnostic potential of 35 Mycobacterium tuberculosis proteins and identification of four novel serological antigens. J. Clin. Microbiol. 43(1), 57-65 (2005). (Pubitemid 40096280)